Abstract
In the context of reconsidering the Quantitative Structure-Activity Relationship (QSAR) methods
at the economical level, namely the optimization rules of OECD, the present review unfolds the key features
of Minimal Sterical, Monte-Carlo and Minimal Topological Difference (MTD) methods, developed for
quantitative treatment of the relations between biological activity of organic chemical compounds (drugs,
pesticides, and so on) and their structures. The initial Minimal Steric Difference (MSD) is completed by the
three-dimensional variant of the MTD method, being the last one referred to here, while the main principles
of validating and guiding a viable QSAR method verified by the analytical-automated MTD, thus enlarging
the perspectives of understanding the chemical-biological interaction at the level of ligand-receptor sites,
cavity, and walls, with a true service to the future adaptive molecular design.
Keywords:
Minimal Topological Difference (MTD), Minimal Steric Difference (MSD), Monte Carlo Difference –
(MCD), Quantitative Structure-Activity Relationship (QSAR), drug design, quantitative treatments, Organization of
Economical Cooperation and Development (OECD).
[2]
Simon, Z.; Chiriac, A.; Holban, Ş.; Ciubotariu, D. Mihalas, G.I.; Minimum steric difference. The MTD meth-od for QSAR studies. Letchworth, Hertfordshire, England: Research Studies Press; New York: Wiley, 1984.
[3]
Ciubotariu, D. Structure - Reactivity Relations within the
class of Carbonic Acid Derivatives. PhD Thesis, Polytechnic
Institute: Bucharest.1987.
[4]
Van de Waterbeemd, H. Quantitative approaches to structure-activity relationships in: The practice of medicinal chemistry; Wermuth, C.G., Ed.; Academic Press: London, 1996, pp. 367-386.
[5]
Ciubotariu, D.; Medeleanu, M.; Gogonea, V. Molecular Descriptors for QSPR/QSAR Studies; Diudea, M., Ed.; Nova Science, New York, 2000, pp. 281-388.
[6]
Niculescu-Duvăz, I.; Ciubotariu, D.; Simon, Z.; Voiculetz, N. QSAR (SAR) models and their use for carcinogenic potency prediction in: Modeling of Cancer Genesis and Prevention; Voiculetz, N.; Balaban, A.T.; Niculescu-Duvăz, I; Simon, Z., Ed.; CRC Press, 1991, pp. 157-214.
[7]
Comprehensive Medicinal Chemistry. Eds.; Pergamon Press: New York,, 1990, Vol. 4, pp. 1-31.
[15]
Goldstein, A.; Aronov, L.; Kalman, S.M. Principle of drug action; John Wiley: New York, 1994, p. 25.
[33]
Putz, M.V. A Fully Integrated Approach: Vol V. Quantum Structure-Activity Relationship (Qu-SAR) In: Apple Academic; Press & CRC Press, 2016; Vol. 5, p. 622.